Balanced approach and positioned for success.

Our business model incorporates a broad based and flexible approach to funding and revenue generation. We have both top tier investors and global pharmaceutical company revenue-generating partnerships. Our unique clinical genetics platform, differentiated therapeutic products and significant drug discovery pipeline ensure we’re well positioned for continued success. For more information, please contact us. >